Not yet taking people in Franciaország1. fázis
Phase I clinical trial of TG4050 combined with nivolumab in patients with Non-Small Cell Lung Cancer.
Key facts
- Where
- Paris, FranciaországSee the site
- Phase
- 1. fázis
Where in Franciaország
- Institut CurieParis, FranciaországToborzás még nem indult
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- Transgene
- Trial code
- EU 2024-514001-65-00
- Record updated
- 2025. március 28.